Illumina Inc. (NASDAQ: ILMN) today announced an expanded clinical oncology portfolio, unlocking the next new solutions to ...

Promoters offloaded 5.26 percent equity stake in PG Electroplast and around 5.8 percent stake in Indigo-parent Interglobe ...

Gene expression leading to alterations in the DNA caused by asbestos exposure may explain the development of malignant ...

Prostate cancer is the most common cancer affecting American men other than skin cancer and the second leading cause of male ...

Postmortem Pathology is proud to announce its comprehensive and professional private autopsy services in Kansas City, Missouri.

NeoGenomics will debut its PanTracer Family and unveil the Paletrra platform at ASCO 2025, advancing precision oncology ...

The market will be near about USD 9.1 Billion in 2025 and USD 31.3 Billion in 2035, growing at a CAGR of 13.1% over the estimated period. The introduction of artificial intelligence and machine ...

During a live event, Gary J. Schiller, MD, reviewed the diagnostics and characteristics of blastic plasmacytoid dendritic cell neoplasm.

Haryana Chief Minister Nayab Singh Saini advocates for a shift to natural farming to improve soil fertility and public health ...

Trends and Industry Outlook (2025) AI technologies are transforming medical diagnostic methods by advancing precision ...

Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful completion of a CLIA-grade analytical validation study of its OncoIncytes ...

At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage ...